Publikation
Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI)
Wissenschaftlicher Artikel/Review - 16.04.2019
Dörner Thomas, Peters Marvin A, Schwenke Holger, Rubbert-Roth Andrea, Krüger Klaus, Kurthen Reiner, Kellner Herbert, Kästner Peter, Engel Andreas, Schmalzing Marc, Iking-Konert Christof, Burmester Gerd-Rüdiger, Schulze-Koops Hendrik, Tony Hans-Peter
Dörner, Thomas
4
0
Schulze-Koops, Hendrik
16
0
Burmester, Gerd-Rüdiger
3
0
Iking-Konert, Christof
1
0
Schmalzing, Marc
2
0
Engel, Andreas
1
0
Kästner, Peter
2
0
Kellner, Herbert
3
0
Kurthen, Reiner
1
0
Krüger, Klaus
2
0
Rubbert-Roth, Andrea
Rheumatologie · Dept. I
52
31
Schwenke, Holger
1
0
Peters, Marvin A
1
0
Tony, Hans-Peter
3
0